[Retracted] Association of the Cholinergic Anti-Inflammatory Pathway Activity with Proinflammatory Factors and Prognosis of Patients with Acute Respiratory Distress Syndrome

Figure 4

Expression levels of inflammatory factors in patients with different types (severe ARDS, n = 30; mild-to-moderate ARDS, n = 35) and survival status (survival ARDS, n = 43; death ARDS, n = 22) of ARDS. (a) The level of IL-6 in peripheral serum of patients with different severity of ARDS was detected by ELISA. (b) The level of TNF-α in peripheral serum of patients with different severity of ARDS was detected by ELISA. (c) The level of TNF-α and IL-6 in peripheral monocytes of patients with different severity of ARDS was detected by Western blot. (d) The level of IL-6 in peripheral serum of ARDS patients with different survival status was detected by ELISA. (e) The level of TNF-α in peripheral serum of patients with different survival status was detected by ELISA. (f) The level of TNF-α and IL-6 in peripheral monocytes of patients with different survival status was detected by Western blot. vs. the severe ARDS group/death ARDS group.

(a)

(b)

(c)

(d)

(e)

(f)